Paweł
Mochalski
*a and
Karl
Unterkofler
ab
aBreath Research Institute of the University of Innsbruck, Rathausplatz 4, A-6850 Dornbirn, Austria. E-mail: pawel.mochalski@uibk.ac.at; Fax: +43-512-504-6724636; Tel: +43-512-504-24636
bVorarlberg University of Applied Sciences, Hochschulstr. 1, A-6850 Dornbirn, Austria
First published on 19th May 2016
Selective reagent ionization time of flight mass spectrometry with NO+ as the reagent ion (SRI-TOF-MS(NO+)) in conjunction with gas chromatography (GC) and head-space solid-phase microextraction (HS-SPME) was used to determine selected volatile organic compounds in human urine. A total of 16 volatiles exhibiting high incidence rates were quantified in the urine of 19 healthy volunteers. Amongst them there were ten ketones (acetone, 2-butanone, 3-methyl-2-butanone, 2-pentanone, 3-methyl-2-pentanone, 4-methyl-2-pentanone, 2-hexanone, 3-hexanone, 2-heptanone, and 4-heptanone), three volatile sulphur compounds (dimethyl sulfide, allyl methyl sulfide, and methyl propyl sulfide), and three heterocyclic compounds (furan, 2-methylfuran, 3-methylfuran). The concentrations of the species under study varied between 0.55 nmol L−1 (0.05 nmol mmol−1creatinine) for allyl methyl sulfide and 11.6 μmol L−1 (1.54 μmol mmol−1creatinine) for acetone considering medians. Limits of detection (LODs) ranged from 0.08 nmol L−1 for allyl methyl sulfide to 1.0 nmol L−1 for acetone and furan (with RSDs ranging from 5 to 9%). The presented experimental setup assists both real-time and GC analyses of volatile organic compounds, which can be performed consecutively using the same analytical system. Such an approach supports the novel concept of hybrid volatolomics, an approach which combines VOC profiles obtained from two or more body fluids to improve and complement the chemical information on the physiological status of an individual.
The composition of urine in humans has received broad attention and a number of sophisticated analytical techniques have been employed to support the identification of volatiles in urine, or urine head-space. These embrace sensor arrays (e-noses),6,11,12 and their combination with gas chromatography,5 selected ion flow tube mass spectrometry (SIFT-MS),14,15 ion mobility spectrometry,7,16 nuclear magnetic resolution spectroscopy (NMR),17 or gas chromatography mass spectrometry (GC-MS).18–21 A compendium of 1849 VOCs forming the human volatolome (pool of all VOCs in human organism) provides 279 species identified in urine.22 Interestingly, the majority of reports yield only qualitative data, or semi-quantitative data, i.e. names of identified compounds, their occurrence in urine samples, or method-specific features of the signal (e.g., peak areas, signal relative strength). Quantitative data are relatively sparse and limited to single compounds, or selected classes of species.21,23–30
Selective reagent ionization time of flight mass spectrometry (SRI-TOF-MS)2,31,32 is a powerful analytical technique for detecting and quantifying VOCs in biological, medical, and environmental matrices. This is due to its versatility, excellent sensitivity, and real-time response. In particular, the last feature is intensively exploited in breath gas analysis to track short-time changes in VOCs levels, which may follow rapid physiological processes occurring in the body.33–36 The employment of a time-of-flight (TOF) mass filter in SRI-TOF-MS instruments provided a higher mass (m/z) resolving power (up to 5000 m/Δm), which supports the separation of isobaric ions; whereas, soft chemical ionization of volatiles by precursor (reagent) ions such as H3O+, NO+, or O2+ facilitates the interpretation of spectra.
Due to the above-mentioned lack of studies reporting the levels of VOCs in human urine, the primary goal of this work was to provide reliable reference concentrations for selected urinary VOCs. Altogether 16 volatiles abundant and omnipresent in urine were pre-selected on the basis of the earlier qualitative studies: 10 ketones, 3 volatile sulphur compounds and 3 heterocyclic compounds.18–20 For this purpose selective reagent ionization time of flight mass spectrometry in conjunction with gas chromatography (GC) and solid-phase microextraction (SPME) as the pre-concentration method was used. While the coupling of the SRI-TOF-MS instrument with a GC column compensated the low selectivity of SRI-TOF-MS and assisted the identification of urinary species, SPME supported the extraction of VOCs of interest from the liquid phase. SPME was proved to be an efficient technique for the extraction of urinary VOCs by numerous studies.18–20,24 Moreover, the SRI-TOF-MS instrument worked with NO+ as the reagent ion (SRI-TOF-MS(NO+)). A valuable feature of NO+ reactions with volatile organic compounds is the diversity of reaction mechanisms.37,38 These embrace charge transfer, hydride ion (H−) transfer, hydroxide ion (OH−) transfer, alkoxide ion (OR−) transfer, and NO+ ion-molecule association. Interestingly, different chemical classes of VOCs undergo characteristic reaction processes with NO+, which is analytically very useful and in some cases helps identify structural isomers.
Urine volatiles were calibrated using human urine samples. Calibration solutions were prepared in three steps. The primary solutions were produced in silanized glass vials (nominal volume 50 mL, real volume 58 mL, Macherey-Nagel, Germany) crimped with 1.3 mm butyl/PTFE septa (Macherey-Nagel, Germany) by adding 1–500 μL (depending on the desired urine concentration) of a pure liquid substance into 57 mL of distilled water (arium® pro, Sartorius Stedim Biotech GmbH, Germany), followed by intensive stirring for 15 minutes at room temperature. Next, the primary solution was additionally diluted by transferring 50 μL of a primary standard into 55 mL of water (1:
1100). The final calibration solutions were prepared by transferring appropriate aliquots of a secondary solution into crimped vials containing urine samples. Calibration curves were obtained on the basis of 2-fold analyses of 5 distinct and independent concentration levels.
For VOCs analyses approximately 18 mL of morning urine were collected into 20 mL glass vials closed with 1.3 mm butyl/PTFE septa (both from Macherey-Nagel, Germany) immediately after urinating. In addition to this, 9 mL of urine were transferred into plastic urine-monovette vessels (Sarstedt, Germany) for the subsequent creatinine analysis. In parallel with urine sampling, one blank sample containing 18 mL of distilled water (arium® pro, Sartorius Stedim Biotech GmbH, Germany) was taken per volunteer using the same materials as in the case of urine sampling for VOCs’ analysis. This was done to identify possible contaminants stemming from sources other than urine. Blank samples were analyzed analogously as urine samples and the resulting concentration levels were subtracted from the respective values in the associated urine samples.
Head space solid-phase microextraction (HS-SPME) was carried out automatically using a multipurpose sampler MPS (Gerstel, Germany). Prior to the extraction, the HS vials were incubated at 37 °C for 20 min in a temperature-controlled agitator and stirred intensively (750 rpm). Extraction was achieved by inserting a 75 μm Carboxen-PDMS SPME fiber (Supelco, Canada)18,19 into the vials and exposing it to the head-space gas for 50 minutes.19 This extraction time was found to be a reasonable trade-off between good detection limits and sampling duration. Subsequently, the fiber was introduced into the inlet of the gas chromatograph where the volatiles of interest were thermally desorbed at 290 °C in a splitless mode (1 min). The fiber was conditioned at 290 °C for 5 minutes prior to each analysis.
An Ionicon Analytik (Innsbruck, Austria) type 8000 SRI-TOF-MS instrument operating in the NO+ mode was used during the analyses.31 The settings of the ion source were chosen as follows: ion source current 5 mA, source voltage (Us) 20 V, source-out voltage (Uso) 70 V, and source valve opening 40%. With these settings the levels of the major impurity ions relative to that of the NO+ precursor ion were H3O+; 0.1–0.2%, O2+; 2–2.5%, and NO2+; 1.5–2%. The NO+/VOCs reactions occurred in the drift tube at a total pressure of 2.3 mbar and a gas temperature of 60 °C. The voltage along the drift section was set to 500 V leading to an E/N ratio of approximately 110 Td. The spectral scans of the TOF analyzer ranged from approximately m/z 2.7 to 500 and were acquired in a time of 500 ms by co-adding 12500 single 40 μs long TOF-MS extractions recorded at a sampling frequency of 1/Δt = 10 GHz. This sampling rate was found to be a reasonable trade-off between the satisfactory number of scans over the peaks needed for quantification and MS sensitivity. The actual mass resolution obtained from the detected peaks was approximately 4000 at m/z 100. The total duration of a single measurement was 54 minutes, which corresponds to the length of the column temperature program. The mass calibration was based on three impurity peaks always present in the spectra: H3O+ (19.0178), 15NO+ (30.9945), and NO2+ (45.9924).
The identification of compounds relied on the exact mass measurement of detected parent ions, the characteristic reaction mechanisms of VOCs with NO+, and the comparison of the retention times of peaks of interest with retention times obtained for standard mixtures prepared from pure compounds. Peak integration was based on the extracted time profiles of parent ions. The retention times of VOCs under scrutiny and parent ions used for their identification and quantification are presented in Table 1.
VOC | CAS | Parent ion formula | Parent ion m/z [Th] | R t [min] | LOD [nmol L−1] | RSD [%] | R 2 | Linear range [nmol L−1] |
---|---|---|---|---|---|---|---|---|
Furan | 110-00-9 | C4H4O+ | 68.0265 | 15.38 | 1.0 | 7.4 | 0.986 | 3.0–31.3 |
Acetone | 67-64-1 | C3H6O·NO+ | 88.0411 | 16.08 | 1.0 | 9.0 | 0.974 | 3.0–52![]() |
Dimethyl sulfide | 75-18-3 | C2H6S+ | 62.0199 | 16.60 | 0.4 | 8.0 | 0.980 | 1.2–24.0 |
Furan, 2-methyl- | 534-22-5 | C5H6O+ | 82.0429 | 21.78 | 0.1 | 6.5 | 0.994 | 0.3–24.0 |
Furan, 3-methyl- | 930-27-8 | C5H6O+ | 82.0429 | 22.18 | 0.1 | 7.6 | 0.992 | 0.3–20.0 |
2-Butanone | 78-93-3 | C4H8O·NO+ | 102.0567 | 22.22 | 0.3 | 8.4 | 0.996 | 0.9–637 |
2-Butanone, 3-methyl- | 563-80-4 | C5H10O·NO+ | 116.0741 | 26.37 | 0.23 | 8.0 | 0.994 | 0.69–23.5 |
Allyl methyl sulfide | 10![]() |
C4H8S+ | 88.0370 | 27.25 | 0.08 | 7.0 | 0.995 | 0.25–17.0 |
2-Pentanone | 107-87-9 | C5H10O·NO+ | 116.0722 | 27.33 | 0.17 | 5.0 | 0.997 | 0.52–720 |
Methyl propyl sulfide | 3877-15-4 | C4H10S+ | 90.0515 | 28.03 | 0.12 | 7.0 | 0.991 | 0.37–18.7 |
2-Pentanone, 4-methyl- | 108-10-1 | C6H12O·NO+ | 130.0880 | 30.83 | 0.29 | 7.5 | 0.994 | 0.88–17.0 |
2-Pentanone, 3-methyl- | 565-61-7 | C6H12O·NO+ | 130.0900 | 31.08 | 0.31 | 8.0 | 0.991 | 0.9–14.0 |
3-Hexanone | 589-38-8 | C6H12O·NO+ | 130.0887 | 31.87 | 0.42 | 8.0 | 0.998 | 1.28–20.4 |
2-Hexanone | 591-78-6 | C6H12O·NO+ | 130.0892 | 32.22 | 0.52 | 8.5 | 0.998 | 1.55–22.6 |
4-Heptanone | 123-19-3 | C7H14O·NO+ | 144.1047 | 35.90 | 0.35 | 9.0 | 0.998 | 1.05–956 |
2-Heptanone | 110-43-0 | C7H14O·NO+ | 144.1075 | 36.53 | 0.31 | 9.2 | 0.993 | 0.92–18.10 |
Table 1 summarizes the parent ions of species under study in SRI-TOF-MS working with NO+ as the reagent ion. Ketones reacted with NO+via ion-molecule association forming NO+M adduct ions;40 whereas, the charge transfer generating the respective M+ ions was the basic ionization mechanism in the case of all furans and sulphur compounds of interest.41,42 The extracted time profiles of these molecular ions were used for the peak integration.
![]() | ||
Fig. 2 Concentration of selected VOCs in human urine. Different colors correspond to different chemical families. |
VOC | Incidence nd(nq) | Range (median) [nmol L−1] | Range (median) [nmol mmol−1creatinine] | Literature data |
---|---|---|---|---|
a Refers to mean value. | ||||
Furan | 19(19) | 1.06–28.8 (11.3) | 0.1–4.75 (0.87) | (a) LOQ (14.7) − 46 nmol L−1 (n = 100)![]() |
Acetone | 19(19) | 2300–107![]() ![]() |
98–18![]() |
(a) 800–17![]() ![]() |
(b) 22![]() ![]() ![]() |
||||
(c) 34![]() ![]() ![]() ![]() |
||||
Dimethyl sulfide | 19(19) | 2.46–84.7 (12.3) | 0.3–6.37 (1.02) | (a) <2.26 nmol L−1 (n = 6)![]() |
Furan, 2-methyl- | 19(19) | 1.74–6.88 (4.06) | 0.2–0.93 (0.34) | |
Furan, 3-methyl- | 19(19) | 1.03–5.59 (2.97) | 0.12–0.92 (0.24) | |
2-Butanone | 19(19) | 32.3–729.2 (292) | 3.59–66.6 (17.7) | |
2-Butanone, 3-methyl- | 19(19) | 2.03–21.5 (6.92) | 0.27–2.48 (0.67) | |
Allyl methyl sulfide | 19(17) | 0.24–9.18 (0.68) | 0.02–1.39 (0.07) | |
2-Pentanone | 19(19) | 104–987 (294) | 7.46–103 (30) | |
Methyl propyl sulfide | 13(7) | 0.32–7.53 (0.76) | 0.03–0.69 (0.06) | |
2-Pentanone, 4-methyl- | 18(18) | 1.48–7.77 (4.28) | 0.11–0.86 (0.37) | |
2-Pentanone, 3-methyl- | 19(19) | 2.07–11 (4.23) | 0.09–1.48 (0.48) | |
3-Hexanone | 19(19) | 2.23–39 (11.93) | 0.53–3.56 (1.04) | |
2-Hexanone | 19(19) | 0.65–34.4 (6.07) | 0.08–5.67 (0.61) | |
4-Heptanone | 19(19) | 18.6–1280 (167) | 3.76–194 (15.2) | (a) 905–7400 (1600) nmol L−1 (n = 51)![]() |
2-Heptanone | 19(19) | 0.61–111 (6.64) | 0.07–17 (0.68) |
The observed concentrations ranged from 0.55 nmol L−1 (0.05 nmol mmol−1creatinine) for allyl methyl sulfide to 11.6 μmol L−1 (1.54 μmol mmol−1creatinine) for acetone considering medians. However, the levels of the majority of species did not exceed 100 nmol L−1 (10 nmol mmol−1creatinine). The highest median concentrations were noted for acetone (11.6 μmol L−1, or 1.54 μmol mmol−1creatinine), 2-pentanone (294 nmol L−1, or 30 nmol mmol−1creatinine), 2-butanone (292 nmol L−1, or 17.7 nmol mmol−1creatinine), and 4-heptanone 167 nmol L−1, or 15.2 nmol mmol−1creatinine). 14 species exhibited incidence rates of 100%. Moreover, 4-methyl-2-pentanone was found in all samples except one; whereas, methyl propyl sulfide was detected in only 13 samples.
Due to the aforementioned shortage of quantitative data on the urine volatolome, it is difficult to relate the results obtained within this study to the literature studies. Nevertheless, several urinary concentration values of species under scrutiny can be found in the literature. In occupational exposure settings Brega et al.25 compared the acetone levels in urine of healthy volunteers and workers exposed to acetone. The concentrations of this compound in urine of controls (n = 20) ranged from 34 to 95 μmol L−1. In the same context, Satoh et al.28 provided acetone levels for a slightly larger control group (n = 66), which were spread around 22.4–41 μmol L−1. More recently, Bouatra et al.17 reported urinary concentrations of acetone in healthy volunteers (n = 22), which fell within the range of 0.8–17.6 μmol mmol−1creatinine (median: 3.9 μmol mmol−1creatinine). The results obtained within this study agree very well with these data. Regarding other ketones, 4-heptanone levels ranging from 905 to 7400 nmol L−1 (median:1600) were observed by Wahl et al.21 in urine of 51 healthy subjects. The presence of 4-heptanone in the human volatolome is being attributed to the metabolism of di(2-ethylhexyl) phthalate (DEHP) and di-2-(ethylhexyl)adipate (DEHA)-plasticizers used in polyvinyl chloride products.43 More specifically, DEHP is a common constituent of medical devices, whereas, DEHA is present in food contact films.44 In humans DEHP and DEHA are rapidly metabolized to 2-ethylhexanol, which is next oxidized to 2-ethylhexanoic acid and finally to 2-heptanone and 4-heptanone.43 The discrepancy between the levels of 4-heptanone obtained within this work and by Wahl et al. can stem from the differences in the exposure of involved populations to the aforementioned plasticizers. Amongst other species furan was determined in urine of 100 healthy individuals by Jun et al.27 It was detected in 56 individuals; however, only 15 concentration values exceeded the LOQ of the method (14.7 nmol L−1). The observed concentrations ranged up to 46 nmol L−1 and agree with the values reported in this work. Single measurements of urinary dimethyl sulfide in humans (n = 6) were performed by Liu et al.26 DMS was detected in urine of 4 volunteers and its levels did not exceed 2.26 nmol L−1. A comparison of the urinary VOCs levels obtained within this study with data from the literature is presented in Table 2.
Two potential pathways may be involved in the production of ketones in humans: (i) oxidation of secondary alcohols catalyzed by alcohol dehydrogenases (ADHs) and (ii) β-oxidation of branched-chain fatty acids. Although primary alcohols are the most preferred substrates for ADHs, they were also demonstrated to convert secondary alcohols into ketones.45–47 For example, 2-hexanone could be the product of 2-hexanol oxidation; whereas, 2-pentanone may stem from 2-pentanol.45 The respective secondary alcohols can derive in turn from dietary sources, or be the products of the alkanes’ metabolism.48–50 Regarding β-oxidation of branched-chain fatty acids, 2-ethylhexanoic acid was shown to be metabolized to 2-heptanone and 4-heptanone as discussed above.43 Perhaps other ketones also can be produced via this metabolic pathway. Acetone is the major ketone produced in the human organism with high abundances in breath,51–53 skin emanations,54,55 and urine.19,20 The sources of these volatiles include (i) endogenous decarboxylation of acetyl–CoA,52,56 (ii) 2-propanol metabolism,46 and (iii) diet. However, the latter two are of minor importance.
The occurrence of allyl methyl sulfide in human tissues is being attributed to garlic intake;57 whereas, methyl propyl sulfide was demonstrated to appear in human breath after onion consumption.58 Furthermore, dimethyl sulfide most likely stems from the metabolization of sulfur-containing amino acids methionine and cysteine in the transamination pathway.59 More specifically, it is formed via the methylation of methyl mercaptane by thiol S-methyltransferase in the liver.60 However, the bacterial production of this volatile cannot be neglected.59
Furan is a common constituent of heat-processed foods (canned, or jarred) and coffee.61 Thus a dietary source seems to contribute primarily to the pool of this specie in humans. Moreover, furan, 2-methylfuran and 3-methylfuran were found to be significantly related to smoking.62
The coupling of selective reagent ionization time of flight mass spectrometry with gas chromatography provides a number of advantages. First, it does not hinder the real-time measurements in SRI-TOF-MS. Consequently, real-time and GC analyses can be performed consecutively using the same analytical system, without additional modifications in the experimental set-up. This feature assists the novel concept of hybrid volatolomics, an approach which combines VOC profiles obtained for two or more body fluids to improve and complement the chemical information on the physiological status of an individual.63 Next, the soft chemical ionization simplifies the product ion distributions and, thereby, improves the baseline and reduces its drift induced by column bleed. This in turn supports integration and detection of chromatographically separated species.
This journal is © The Royal Society of Chemistry 2016 |